Boston, MA - Whitney W. Woodmansee, MD, has been named the Director of the Clinical Neuroendocrine Program in the Division of Endocrinology, Diabetes and Hypertension and the Department of Neurosurgery at Brigham and Women's Hospital (BWH).
"We are pleased to welcome Dr. Woodmansee as a new integral member of our Pituitary/Neuroendocrine Center. Her experience, skills and enthusiasm make her a wonderful complement to our current faculty," said Edward R. Laws, MD, Director of the Pituitary and Neuroendocrine Center at BWH.
Dr. Woodmansee joins Drs. Ursula B. Kaiser and Edward R. Laws and their support staff in a multidisciplinary setting designed to diagnose and treat patients with pituitary and allied disorders. Her research contributions have focused on somatostatin receptor biology and physiology, metabolic derangements in thyroid disease, regulation of thyrotrope function, and hypopituitarism.
Woodmansee received her Bachelor's degree in Molecular Biology and Master's degree in Behavioral Neurosciences from the University of Colorado, Boulder. Her M.D., postgraduate training in Internal Medicine and Fellowship in Endocrinology were obtained at the University of Colorado School of Medicine in Denver, the latter under the leadership of Dr. E. C. "Chip" Ridgway. She is Board Certified in Endocrinology, Diabetes and Metabolism.
Prior academic positions include Instructor, Assistant Professor, and Associate Professor of Medicine at the University of Colorado Denver, School of Medicine. Woodmansee was a founding member of the Pituitary Center there, highly regarded as a clinician, researcher, and teacher. She is a member of the American College of Physicians, Endocrine Society, American Thyroid Association, and Pituitary Society, among others.
About Brigham and Women's Hospital:-
Brigham and Women's Hospital (BWH) is a 777-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. In July of 2008, the hospital opened the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 860 physician-investigators and renowned biomedical scientists and faculty supported by more than $416 M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information about BWH, please visit http://www.brighamandwomens.org/
